{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Organogenesis Holdings Inc. "},"Symbol":{"label":"Symbol","value":"ORGO"},"Address":{"label":"Address","value":"85 DAN ROAD, CANTON, Massachusetts, 02021, United States"},"Phone":{"label":"Phone","value":"+1 781 575-0775"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others."},"CompanyUrl":{"label":"Company Url","value":"https://www.organogenesis.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Gary S. Gillheeney","title":"Chairman, President & Chief Executive Officer"},{"name":"Patrick R. Bilbo","title":"Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}